James A Bonner

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Machine Learning

Klebsiella Pneumoniae

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Lewis Zhichang Shi, Hongxing Shen, Oluwagbemiga A Ojo, James A Bonner
HiJAKing Immunotherapy-Resistant Melanoma for a Cure. The oncologist 28 (3) (2023)
Lewis Zhichang Shi, Hongxing Shen, Oluwagbemiga A Ojo, James A Bonner
HiJAKing Immunotherapy-Resistant Melanoma for a Cure. The oncologist (2023)
Hongxing Shen, Fengyuan Huang, Xiangmin Zhang, Oluwagbemiga A Ojo, Yuebin Li, Hoa Quang Trummell, Joshua C Anderson, John Fiveash, Markus Bredel, Eddy Shih-Hsin Yang, Christopher D Willey, Zechen Chong, James A Bonner, Lewis Zhichang Shi
Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling. Nature communications 13 (1) (2022)
Sindhu Nair, Hoa Q Trummell, Rajani Rajbhandari, Nanda K Thudi, Susan E Nozell, Jason M Warram, Christopher D Willey, Eddy S Yang, William J Placzek, James A Bonner, Markus Bredel
Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer. PloS one 15 (2) (2020)